Table 4 Associations between the presence of four potentially pathogenic MT-CO3 alleles and clinical phenotypes in gout
From: Next-generation sequencing profiling of mitochondrial genomes in gout
Variables | Potentially pathogenic MT-CO3 alleles | P | |
|---|---|---|---|
+ | – | ||
Number (percentage) | 4 (7.69) | 48 (92.31) | Â |
Age (years; mean ± SD) | 50.00 ± 12.99 | 51.73 ± 10.77 | 0.798 |
Uric acid (mg/dl; mean ± SD) | 6.60 ± 2.07 | 7.71 ± 1.63 | 0.236 |
BMI (kg/m2; mean ± SD) | 23.87 ± 2.09 | 26.70 ± 3.74 | 0.118 |
Diabetes mellitus (n (%)) | 1 (25.00) | 3 (6.25) | 0.281 |
Fasting glucose (mg/dl; mean ± SD) | 98.50 ± 14.89 | 99.90 ± 19.31 | 0.973 |
Total cholesterol (mg/dl; mean ± SD) | 192.20 ± 45.17 | 191.00 ± 39.92 | 0.693 |
HDL (mg/dl; mean ± SD) | 61.00 ± 12.41 | 47.17 ± 12.60 | 0.034 |
LDL (mg/dl; mean ± SD) | 119.30 ± 34.81 | 119.50 ± 38.81 | 0.918 |
Triglycerides (mg/dl; mean ± SD) | 137.80 ± 86.89 | 159.10 ± 100.30 | 0.706 |